Evidence map›Paper›PMID 32005943›Full record

ArticleScientific reports2020

Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.

Antonio Juan Ribelles, Sandra Barberá, Yania Yáñez, Pablo Gargallo, Vanessa Segura, Bárbara Juan, Rosa Noguera, Marta Piqueras, Victoria Fornés-Ferrer, Jaime Font de Mora and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Antonio Juan RibellesPediatric Oncology and Hematology Unit, La Fe University Hospital, Valencia, Spain. juan_antrib@gva.es.
Sandra BarberáMedicine Faculty, Valencia, Spain.
Yania YáñezClinical and Translational Oncology Research Group, Investigation Institute La Fe, Valencia, Spain.
Pablo GargalloClinical and Translational Oncology Research Group, Investigation Institute La Fe, Valencia, Spain.
Vanessa SeguraClinical and Translational Oncology Research Group, Investigation Institute La Fe, Valencia, Spain.
Bárbara JuanMedicine Faculty, Valencia, Spain.
Rosa NogueraPathology Department, Medicine Faculty. Hospital Clínico, Valencia, Spain.
Marta PiquerasPathology Department, Medicine Faculty. Hospital Clínico, Valencia, Spain.
Victoria Fornés-FerrerBiostatistics Department, Investigation Institute La Fe, Valencia, Spain.
Jaime Font de MoraClinical and Translational Oncology Research Group, Investigation Institute La Fe, Valencia, Spain.
Adela CañetePediatric Oncology and Hematology Unit, La Fe University Hospital, Valencia, Spain.
Victoria CastelClinical and Translational Oncology Research Group, Investigation Institute La Fe, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32005943
PMCPMC6994581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.